These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 14652070)
21. Tethered ligand library for discovery of peptide agonists. Chen J; Bernstein HS; Chen M; Wang L; Ishii M; Turck CW; Coughlin SR J Biol Chem; 1995 Oct; 270(40):23398-401. PubMed ID: 7559498 [TBL] [Abstract][Full Text] [Related]
22. The domino effect triggered by the tethered ligand of the protease activated receptors. Han X; Nieman MT Thromb Res; 2020 Dec; 196():87-98. PubMed ID: 32853981 [TBL] [Abstract][Full Text] [Related]
23. How the protease thrombin talks to cells. Coughlin SR Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11023-7. PubMed ID: 10500117 [TBL] [Abstract][Full Text] [Related]
24. Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells. Bae JS; Yang L; Rezaie AR J Thromb Haemost; 2008 Jun; 6(6):954-61. PubMed ID: 18284602 [TBL] [Abstract][Full Text] [Related]
25. Thrombin Exosite Maturation and Ligand Binding at ABE II Help Stabilize PAR-Binding Competent Conformation at ABE I. Billur R; Sabo TM; Maurer MC Biochemistry; 2019 Feb; 58(8):1048-1060. PubMed ID: 30672691 [TBL] [Abstract][Full Text] [Related]
26. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1. Myles T; Le Bonniec BF; Stone SR Eur J Biochem; 2001 Jan; 268(1):70-7. PubMed ID: 11121104 [TBL] [Abstract][Full Text] [Related]
27. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand. Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389 [TBL] [Abstract][Full Text] [Related]
29. Progress in the understanding of protease-activated receptors. Gabazza EC; Taguchi O; Kamada H; Hayashi T; Adachi Y; Suzuki K Int J Hematol; 2004 Feb; 79(2):117-22. PubMed ID: 15005337 [TBL] [Abstract][Full Text] [Related]
30. Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster. Kahn M; Ishii K; Kuo WL; Piper M; Connolly A; Shi YP; Wu R; Lin CC; Coughlin SR Mol Med; 1996 May; 2(3):349-57. PubMed ID: 8784787 [TBL] [Abstract][Full Text] [Related]
31. Molecular mapping of thrombin-receptor interactions. Ayala YM; Cantwell AM; Rose T; Bush LA; Arosio D; Di Cera E Proteins; 2001 Nov; 45(2):107-16. PubMed ID: 11562940 [TBL] [Abstract][Full Text] [Related]
32. Desensitisation of protease-activated receptor-1 (PAR-1) in rat astrocytes: evidence for a novel mechanism for terminating Ca2+ signalling evoked by the tethered ligand. Ubl JJ; Sergeeva M; Reiser G J Physiol; 2000 Jun; 525 Pt 2(Pt 2):319-30. PubMed ID: 10835036 [TBL] [Abstract][Full Text] [Related]
33. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors. Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460 [TBL] [Abstract][Full Text] [Related]
34. A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization. Swift S; Xu J; Trivedi V; Austin KM; Tressel SL; Zhang L; Covic L; Kuliopulos A J Biol Chem; 2010 Apr; 285(15):11402-10. PubMed ID: 20164183 [TBL] [Abstract][Full Text] [Related]
36. Allosteric modulation of protease-activated receptor signaling. Canto I; Soh UJ; Trejo J Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248 [TBL] [Abstract][Full Text] [Related]
37. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Gerszten RE; Chen J; Ishii M; Ishii K; Wang L; Nanevicz T; Turck CW; Vu TK; Coughlin SR Nature; 1994 Apr; 368(6472):648-51. PubMed ID: 8145852 [TBL] [Abstract][Full Text] [Related]
38. Thrombin receptor antagonists; recent advances in PAR-1 antagonist development. Anderluh M; Dolenc MS Curr Med Chem; 2002 Jul; 9(13):1229-50. PubMed ID: 12052165 [TBL] [Abstract][Full Text] [Related]
39. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies. Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045 [TBL] [Abstract][Full Text] [Related]
40. A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets. Sánchez Centellas D; Gudlur S; Vicente-Carrillo A; Ramström S; Lindahl TL Thromb Res; 2017 Jun; 154():84-92. PubMed ID: 28448853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]